Concord Drugs Limited

Pharmaceutical company manufacturing bulk drugs and active pharmaceutical intermediates with GMP certification.

1995 | Active
Last Updated:

Concord Drugs Profile

Key Indicators

  • Authorised Capital ₹ 11.00 Cr
  • Paid Up Capital ₹ 10.00 Cr
  • Company Age 29 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 18.25 Cr
  • Satisfied Charges ₹ 7.40 Cr
  • Revenue Growth 14.78%
  • Profit Growth -51.42%
  • Ebitda 73.69%
  • Net Worth 5.96%
  • Total Assets 13.16%

About Concord Drugs

Concord Drugs Limited (CDL) is a leading Public Limited Indian Non-Government Company incorporated in India on 24 April 1995 and has a history of 29 years and 11 months. Its registered office is in Na, Telangana.

It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 538965.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 11.00 Cr and a paid-up capital of Rs 10.00 Cr.

The company currently has active open charges totaling ₹18.25 Cr. The company has closed loans amounting to ₹7.40 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Concord Drugs Limited India are Koni Seelam as CFO and Namratha as Company Secretary. Nagi Seelam, Ramchandra Kommula, Koni Seelam, and Three other members serve as directors at the Company.

Company Details

  • Location Na, Telangana
  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    L24230TG1995PLC020093

  • Company No.

    020093

  • Stock Symbol

    BSE : 538965

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    24 Apr 1995

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Listed

  • ROC Code

    Roc Hyderabad

Industry

Pharma

What products or services does Concord Drugs Limited offer?

Concord Drugs Limited offers a wide range of products and services, including Hand Sanitizer & Disinfectant, Alcohol Based Hand Sanitizer.

Who are the key members and board of directors at Concord Drugs?

Executive Team (3)

NameDesignationAppointment DateStatus
Koni Seelam Country flag representing In CFO30-Sep-2021Current
Nagi Seelam Country flag representing In Managing Director04-Apr-2003Current
Namratha Country flag representing In Company Secretary08-Apr-2024Current

Board Members (5)

NameDesignationAppointment DateStatus
Koni Seelam Country flag representing In Whole-Time Director and Cfo 10-Jun-2011Current
Ramchandra Kommula Country flag representing In Director 30-Mar-2019Current
Seelam Manojkumarreddy Country flag representing In Whole-Time Director 13-Aug-2021Current
Nagavenkatahareeshkumar Solleti Country flag representing In Director 13-Feb-2021Current
Sumeela Kasu Country flag representing In Director 01-Jun-2022Current

Financial Performance of Concord Drugs.

Concord Drugs Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 14.78% increase. The company also saw a substantial fall in profitability, with a 51.42% decrease in profit. The company's net worth moved up by a moderate rise of 5.96%.

Concord Drugs revenue growth over time
Concord Drugs profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
14.78%
Revenue from Operations
14.80%
Total Assets
13.16%
Profit or Loss
-51.42%
Net Worth
5.96%
EBITDA
73.69%

What is the Ownership and Shareholding Structure of Concord Drugs?

In 2022, Concord Drugs had a promoter holding of 49.00% and a public holding of 50.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹18.25 Cr

Satisfied Charges

₹7.40 Cr

Charges Breakdown by Lending Institutions

  • State Bank Of India : 18.25 Cr

Latest Charge Details

DateLenderAmountStatus
17 Dec 2011State Bank Of India₹18.25 CrOpen
11 Mar 2022Others₹5.00 CrSatisfied
10 Nov 2005Punjab National Bank₹1.40 CrSatisfied
01 Jan 1998Small Industries Development Bank Of India₹5.00 MSatisfied
17 Oct 1997Small Industries Development Bank Of India₹5.00 MSatisfied

How Many Employees Work at Concord Drugs?

Concord Drugs has a workforce of 21 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Concord Drugs Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Concord Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Concord Drugs's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Concord Drugs

Recent activity within the organization

  • Annual General Meeting

    Concord Drugs Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Charges

    A charge with State Bank Of India of Rs. 18.25 Cr registered on 17 Dec 2011 with Charge ID 10394597 was modified on 31 Jul 2024.

  • Director Appointment

    Namratha was appointed as a Company Secretary was appointed as a Company Secretary on 08 Apr 2024 & has been associated with this company since 11 months 21 days .

  • Balance Sheet

    Concord Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.

  • Charges

    A charge registered on 11 Mar 2022 via Charge ID 100568210 with Others was fully satisfied on 18 Apr 2023.

  • Director Appointment

    Sumeela Kasu was appointed as a Director was appointed as a Director on 01 Jun 2022 & has been associated with this company since 2 years 9 months .

Frequently asked questions

  • What is the Incorporation or founding date of Concord Drugs Limited?

    Concord Drugs Limited was incorporated on 24 Apr 1995.

  • What is authorized share capital and paid-up capital of Concord Drugs Limited?

    The authorized share capital of Concord Drugs Limited is ₹ 11.00 Cr and paid-up capital is ₹ 10.00 Cr.

  • Who are the current board members & directors of Concord Drugs Limited?

    Currently 8 directors are associated with Concord Drugs Limited.

    • Nagi Reddy Seelam
    • Ramchandra Reddy Kommula
    • Koni Reddy Seelam
    • Seelam Manojkumarreddy
    • Nagavenkatahareeshkumar Solleti
    • Sumeela Kasu
    • Koni Reddy Seelam
    • Namratha

  • What is the registered address of Concord Drugs Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Concord Drugs Limited is Survey No.249, Brahmapally Village Hayatgar Mandal R.R.D Ist-501511 Telanga India, Na, Telangana.

  • What is the corporate identification number (CIN) and company number of Concord Drugs Limited?

    The corporate identification number (CIN) of Concord Drugs Limited is L24230TG1995PLC020093 and the company number is 020093 as per Ministry of Corporate Affairs (MCA).

  • Is Concord Drugs Limited registered with any stock exchange in India?

    Yes, Concord Drugs Limited is registered on Bombay Stock Exchange (BSE).

  • What is the official website of Concord Drugs Limited?

    The Official website of Concord Drugs Limited is https://www.concorddrugs.in

  • What has been the recent revenue trend for Concord Drugs Limited?

    According to the financial reports for the fiscal year 2022, the revenue trend for Concord Drugs Limited has risen by 14.78%.

  • How many employees does Concord Drugs Limited currently have?

    As Per 2022 financial reports, 21 employees are currently employed by Concord Drugs Limited.

  • What change has been observed in the net worth of Concord Drugs Limited, and by what percentage?

    The financial reports for the fiscal year 2022 indicates that The net worth of Concord Drugs Limited has experienced an upsurge of 5.96%.

  • What are the total open charges for Concord Drugs Limited?

    As per the financial statements for fiscal Year 2022, The total open charges for Concord Drugs Limited amount to ₹ 18.25 Cr.

  • When was the last Balance Sheet of Concord Drugs Limited filed with the ROC?

    The most recent Balance Sheet for Concord Drugs Limited was filed with the ROC on 31 Mar 2024.

People also Viewed